EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

NAA50-mediated SLU7 stabilization promotes cisplatin resistance in bladder cancer via regulating MAP3K3 mRNA nuclear export and p38 MAPK activation

Benlin Wang, Xianchong Zheng, Qingsheng Hua, Feng Zou, Tao Huang, Jiawei Chen

Cellular Oncology · 18.05.2026 · 49 (4)

DOI: 10.1007/s13402-026-01219-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 18.05.2026. Verfasst von Benlin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China. Hauptthemen laut MEDLINE: Cisplatin, Urinary Bladder Neoplasms, Drug Resistance, Neoplasm, p38 Mitogen-Activated Protein Kinases. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinUrinary Bladder NeoplasmsDrug Resistance, Neoplasmp38 Mitogen-Activated Protein KinasesMAP Kinase Kinase 3N-Terminal Acetyltransferase EN-Terminal Acetyltransferase AHumansAnimalsCell Line, TumorRNA, MessengerActive Transport, Cell NucleusCell NucleusFemaleMice, NudeGene Expression Regulation, NeoplasticMiceXenograft Model Antitumor AssaysEnzyme ActivationMAP Kinase Kinase Kinase 3

Stichwörter der Autor:innen

BLCACisplatin resistanceMAP3K3NAA50SLU7

Substanzen

Cisplatinp38 Mitogen-Activated Protein KinasesRNA, MessengerMAP Kinase Kinase 3MAP3K3 protein, humanN-Terminal Acetyltransferase EN-Terminal Acetyltransferase AMAP Kinase Kinase Kinase 3

Autor:innen und Institutionen

  • Department of Urology, The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China.
  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China. zhengxc@sysucc.org.cn.
  • Department of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China. zhengxc@sysucc.org.cn.
  • Department of Urology, The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China. sddlhuangtao@163.com.
  • Department of Urology, The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China. miwaicjw@163.com.

Zitieren

APA

Wang, B., Zheng, X., Hua, Q., Zou, F., Huang, T., & Chen, J. (2026). NAA50-mediated SLU7 stabilization promotes cisplatin resistance in bladder cancer via regulating MAP3K3 mRNA nuclear export and p38 MAPK activation. Cellular Oncology, 49(4). https://doi.org/10.1007/s13402-026-01219-0

Vancouver

Wang B, Zheng X, Hua Q, Zou F, Huang T, Chen J. NAA50-mediated SLU7 stabilization promotes cisplatin resistance in bladder cancer via regulating MAP3K3 mRNA nuclear export and p38 MAPK activation. Cellular Oncology. 2026;49(4). doi:10.1007/s13402-026-01219-0

BibTeX
@article{Wang2026,
  author = {Wang, Benlin and Zheng, Xianchong and Hua, Qingsheng and Zou, Feng and Huang, Tao and Chen, Jiawei},
  title = {NAA50-mediated SLU7 stabilization promotes cisplatin resistance in bladder cancer via regulating MAP3K3 mRNA nuclear export and p38 MAPK activation},
  journal = {Cellular Oncology},
  year = {2026},
  volume = {49},
  number = {4},
  doi = {10.1007/s13402-026-01219-0}
}
Kostenlos starten →